Medical Devices

Wound Healing

With our testing methods, Noble Life Sciences brings comprehensive expertise to your preclinical device programs.

Our medical device division provides surgical expertise and utilizes state-of-the-art equipment to advance your would healing device technology.

Your choice for quality preclinical development

Wound Healing Models

Wound healing is a natural, complex, and dynamic response to bodily trauma or injury. While some patients reproduce devitalized or missing tissue layers or cellular structures on their own, experts seek ways to improve the efficiency and efficacy of this process.

Noble Life Sciences is a trusted partner for testing devices and therapies for innovative wound healing and wound care solutions. We are here to help your preclinical study and advance your wound healing technology.

Our areas of expertise include:

  • Full Thickness Defect
  • Skin Graft
  • Burn Models
  • Diabetic Models
  • Full Thickness Excisional and Incisional Wounding and Repair Analysis
  • Stem cell/IPS/MSC Implantation Models
  • Electrostimulation Models
  • Motility Assays—Fluorescence and Light Microscope
  • Scar Tissue Tensile Strength Analysis and Histology
  • Interstitial Fluid Collection and Analysis
  • Nutritional and Pharmaceutical Supplementation

Noble Talent

Expert Wound Healing/
Traumatic Injury Staff

Noble Life takes pride in its knowledge, expertise, and customer satisfaction. With over 15 years of experience in the medical device community, we are driven to provide high-quality, flexible, customized, and cost-effective research and development solutions for you.

Ali Mohammadabadi, Ph.D.

Ali Mohammadabadi, Ph.D.

Study Director

Ivan Tatarov, D.V.M.

Ivan Tatarov, D.V.M.

Clinical Veterinarian

Let’s talk about our Wound Healing device services

Resources & White Papers

PASSIONATE ABOUT COLLABORATING FOR A CURE

Mouse Peritonitis/Sepsis Model of MRSA Infection

Mouse Peritonitis/Sepsis Model of MRSA Infection

Noble Life Sciences, in collaboration with ImQuest Biosciences, has optimized the peritonitis/sepsis mouse model to screen for new antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). The model’s popularity derives from its ease of use with small and expensive animals, short-duration experiments with reproducible infections, and simple end-points.

read more